Pharma-biotech partnerships take on new urgency as patent cliffs loom
Clarivate
MAY 31, 2023
A glance at the 2022 top selling drugs for the biggest pharma companies reveals how dependent many large pharmas are on a small basket of products – most acquired through partnerships or acquisitions – that are nearing loss of exclusivity. billion in 2022. Of the biggest spenders in 2022, Merck/MSD opened its wallet the widest.
Let's personalize your content